Siemens' syngo TrueD is designed for oncology, supporting PET/CT, SPECT/CT as well as CT or MR fused with PET or SPECT. The syngo TrueD was de-signed to allow physicians to compare patient scans from different time points (such as pre- and post-therapy) and provide advanced image analysis and comparison.
May 2008
Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...
February 13, 2026 
Feb. 9, 2026 — MRIguidance, a MedTech company developing BoneMRI, a radiation-free bone imaging solution, has appointed ...
February 09, 2026 
Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...
February 06, 2026 
Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...
February 03, 2026 
Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...
January 28, 2026 
Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...
January 27, 2026 
Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...
January 27, 2026 
Dec. 12, 2025 — Hyperfine, Inc. has announced that it has received FDA clearance for a new multi-direction diffusion ...
December 15, 2025 
Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...
December 10, 2025 
Healthcare has reached a critical juncture. The World Economic Forum estimates that global medical costs will see double ...
December 04, 2025 